AI Engines For more Details: Perplexity Kagi Labs You
Emotional Regulation: Music therapy can help individuals regulate their emotions and manage stress, anxiety, and depression. Listening to music or creating music can evoke positive emotions, provide a sense of comfort, and serve as a healthy outlet for expressing feelings.
Pain Management: Music therapy has been shown to reduce pain perception and improve pain tolerance in individuals with chronic pain conditions, postoperative pain, or during medical procedures. Music can distract from pain sensations, promote relaxation, and release endorphins, which are natural pain-relieving chemicals in the brain.
Cognitive Enhancement: Music therapy can enhance cognitive function and stimulate brain activity in individuals with neurological disorders such as Alzheimer's disease, Parkinson's disease, and traumatic brain injury. Engaging in music-related activities, such as singing, playing instruments, and rhythmic exercises, can improve memory, attention, and concentration.
Speech and Language Development: Music therapy techniques, such as singing and rhythm-based exercises, can support speech and language development in children with developmental delays, speech disorders, or autism spectrum disorder. Music facilitates communication, encourages vocalization, and enhances auditory processing skills.
Motor Skills Rehabilitation: Music therapy interventions involving rhythmic movements, coordination exercises, and instrument playing can improve motor skills and coordination in individuals recovering from stroke, spinal cord injury, or other physical impairments. Music-based activities promote muscle relaxation, motor planning, and sensory-motor integration.
Social Interaction: Music therapy encourages social interaction, communication, and interpersonal skills development in group settings. Collaborative music-making activities foster a sense of belonging, cooperation, and mutual support among participants, including those with autism, social anxiety, or communication difficulties.
Quality of Life: Music therapy enhances overall quality of life and promotes a sense of well-being in individuals facing terminal illness, chronic health conditions, or end-of-life care. Music interventions provide comfort, spiritual support, and opportunities for self-expression, helping individuals cope with pain, grief, and existential concerns.
Stress Reduction: Music therapy techniques, such as guided imagery, progressive muscle relaxation, and mindfulness meditation with music, can reduce physiological arousal, lower blood pressure, and promote relaxation responses. Listening to calming music or engaging in music-based relaxation exercises can alleviate stress and promote mental clarity.
Behavioral Management: Music therapy can be effective in managing challenging behaviors and promoting self-regulation in children and adults with behavioral disorders, attention deficit hyperactivity disorder (ADHD), or emotional disturbances. Music-based interventions help channel energy, improve impulse control, and enhance emotional self-awareness.
Rank | Probiotic | Impact |
---|---|---|
species | Lactobacillus acidophilus | Increases |
species | Lactobacillus crispatus | Increases |
species | Lactobacillus gasseri | Increases |
species | Lactobacillus helveticus | Increases |
species | Lactobacillus jensenii | Increases |
species | Lactobacillus johnsonii | Increases |
species | Lactobacillus kefiranofaciens | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Acne | 0.8 | 0.8 | |
ADHD | 0.6 | 0.6 | |
Allergic Rhinitis (Hay Fever) | 0.7 | 0.7 | |
Allergies | 0.8 | 0.8 | 0 |
Alzheimer's disease | 0.2 | 0.6 | -2 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.6 | -0.6 | |
Ankylosing spondylitis | 0.8 | 0.8 | |
Asthma | 0.8 | 0.6 | 0.33 |
Atherosclerosis | 0.6 | -0.6 | |
Atrial fibrillation | 0.6 | -0.6 | |
Autism | 0.6 | 0.8 | -0.33 |
Autoimmune Disease | 0.7 | 0.7 | |
Brain Trauma | 0.6 | 0.6 | |
Cancer (General) | 0.6 | 0.6 | |
Celiac Disease | 0.6 | 0.6 | 0 |
Chronic Fatigue Syndrome | 0.6 | 0.6 | |
Chronic Kidney Disease | 0.8 | 0.8 | |
Chronic Obstructive Pulmonary Disease (COPD) | 0.6 | -0.6 | |
Cognitive Function | 0.8 | 0.2 | 3 |
Colorectal Cancer | 0.6 | 0.8 | -0.33 |
Coronary artery disease | 0.6 | 0.6 | |
COVID-19 | 0.6 | 0.6 | 0 |
Crohn's Disease | 0.6 | 0.6 | 0 |
d-lactic acidosis (one form of brain fog) | 1 | -1 | |
Denture Wearers Oral Shifts | 0.6 | 0.6 | |
Depression | 0.8 | 1.1 | -0.38 |
Eczema | 0.2 | 0.2 | |
Endometriosis | 0.9 | 0.6 | 0.5 |
Epilepsy | 0.6 | 0.6 | |
Fibromyalgia | 0.6 | 0.6 | 0 |
Functional constipation / chronic idiopathic constipation | 0.6 | 0.6 | |
gallstone disease (gsd) | 0.6 | 0.2 | 2 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.2 | 0.2 | |
Graves' disease | 0.6 | 0.6 | 0 |
Hashimoto's thyroiditis | 0.8 | 0.8 | |
Heart Failure | 0.6 | 0.6 | 0 |
High Histamine/low DAO | 0.6 | -0.6 | |
hyperglycemia | 0.6 | 0.6 | |
Hyperlipidemia (High Blood Fats) | 0.8 | 0.8 | |
hypertension (High Blood Pressure | 0.6 | 0.6 | 0 |
Hypoxia | 0.6 | 0.6 | 0 |
IgA nephropathy (IgAN) | 0.6 | 0.6 | |
Inflammatory Bowel Disease | 0.8 | 0.6 | 0.33 |
Insomnia | 0.2 | 0.7 | -2.5 |
Intracranial aneurysms | 0.6 | 0.6 | |
Irritable Bowel Syndrome | 0.6 | 0.6 | 0 |
ischemic stroke | 0.6 | -0.6 | |
Liver Cirrhosis | 0.8 | 0.6 | 0.33 |
Long COVID | 0.6 | 0.8 | -0.33 |
ME/CFS with IBS | |||
ME/CFS without IBS | |||
Menopause | 0.7 | 0.7 | |
Metabolic Syndrome | 0.6 | 0.8 | -0.33 |
Mood Disorders | 0.8 | 1.3 | -0.63 |
multiple chemical sensitivity [MCS] | 0.6 | -0.6 | |
Multiple Sclerosis | 1 | 0.6 | 0.67 |
Multiple system atrophy (MSA) | 0.6 | -0.6 | |
Neuropathy (all types) | 0.6 | -0.6 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.6 | 0.8 | -0.33 |
NonCeliac Gluten Sensitivity | 0.6 | 0.6 | |
Obesity | 0.8 | 0.6 | 0.33 |
obsessive-compulsive disorder | 0.6 | 0.6 | |
Osteoporosis | 0.6 | 0.6 | 0 |
Parkinson's Disease | 0.8 | 1 | -0.25 |
Polycystic ovary syndrome | 0.6 | 0.6 | 0 |
primary biliary cholangitis | 0.6 | -0.6 | |
Primary sclerosing cholangitis | 0.6 | -0.6 | |
Psoriasis | 0.6 | -0.6 | |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.8 | 0.8 | 0 |
Rosacea | 0.6 | 0.6 | |
Schizophrenia | 0.8 | 1 | -0.25 |
Sjögren syndrome | 0.2 | -0.2 | |
Slow gastric motility / Gastroparesis | 0.6 | 0.6 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.6 | -0.6 | |
Stress / posttraumatic stress disorder | 0.6 | -0.6 | |
Systemic Lupus Erythematosus | 0.8 | 0.6 | 0.33 |
Tourette syndrome | 0.6 | 0.6 | |
Type 1 Diabetes | 0.6 | 0.6 | 0 |
Type 2 Diabetes | 0.6 | 0.8 | -0.33 |
Ulcerative colitis | 0.8 | 0.8 | 0 |
Unhealthy Ageing | 0.7 | 0.6 | 0.17 |